{"text": ["Gilead", "Partners", "with", "Scholar", "Rock", "for", "Fibrotic", "Disease", "Drugs"], "created_at": "2018-12-20 22:59:10"}
{"text": ["AbbVie", "Rises", "3%"], "created_at": "2018-12-20 22:18:02"}
{"text": ["Notable", "ETF", "Inflow", "Detected", "-", "XLV,", "ABBV,", "ABT,", "CVS"], "created_at": "2018-12-20 17:08:38"}
{"text": ["Notable", "ETF", "Inflow", "Detected", "-", "XLV,", "ABBV,", "ABT,", "CVS"], "created_at": "2018-12-20 17:08:38"}
{"text": ["AbbVie", "Submits", "New", "Drug", "Application", "to", "U.S.", "FDA", "and", "Marketing", "Authorization", "Application", "to", "EMA", "for", "Upadacitinib", "for", "Treatment", "of", "Adults", "with", "Moderate", "to", "Severe", "Rheumatoid", "Arthritis"], "created_at": "2018-12-20 13:50:00"}
{"text": ["AbbVie", "to", "Present", "at", "the", "37th", "Annual", "J.P.", "Morgan", "Healthcare", "Conference"], "created_at": "2018-12-20 13:00:00"}
{"text": ["3", "Top", "Healthcare", "Stocks", "to", "Buy", "in", "December"], "created_at": "2018-12-20 11:00:00"}
